Biology
Prion Diseases: Transmission, Diagnosis, and Therapeutic Challenges
Quick fact
Prions are the only known infectious agents that lack nucleic acids (DNA or RNA). They are just misfolded proteins, yet they can transmit disease between individuals, triggering a cascade of misfolding in the host's normal proteins.
Why this is interesting
You've probably heard of diseases caused by viruses, bacteria, or fungi—but what if a disease could be caused by just a misfolded protein? Imagine an infectious agent with no DNA or RNA, yet capable of spreading and destroying the brain. That's the astonishing reality of prion diseases, a group of rare but invariably fatal disorders that challenge our fundamental understanding of biology and medicine.
Read the full explanation
Understanding Prion Diseases: Transmission, Diagnosis, and Therapeutic Challenges
To grasp prion diseases, think of a normal protein as a piece of paper folded into a functional shape—say, a paper airplane. Sometimes, that paper can refold into a different, stable shape—like a crumpled ball. In prion diseases, the 'crumpled ball' shape (called PrPSc) can act as a template, forcing neighboring normal proteins (PrPC) to also refold into the crumpled shape. This process is like a chain reaction: once one protein misfolds, it can convert many others, forming clumps that damage and kill neurons in the brain. These misfolded proteins are called prions, and they can be transmitted from one person (or animal) to another through contact with contaminated tissue, such as during certain medical procedures or even through ingestion, as seen in kuru and variant Creutzfeldt-Jakob disease from contaminated beef.
A deeper explanation
The mechanism of prion diseases hinges on the conversion of the normal prion protein (PrPC) into the disease-associated isoform (PrPSc). PrPC is a cellular protein found mainly in the brain, and its normal function is still not fully understood, but it is thought to play roles in copper binding, stress response, and synaptic function. PrPSc is the same protein but adopts a different three-dimensional structure, particularly enriched in beta-sheet content, making it resistant to degradation and prone to aggregation. The conversion occurs when PrPSc comes into contact with PrPC, inducing the normal protein to refold into the pathogenic form. This propagation can occur in two ways: spontaneously (as in sporadic CJD), genetically (due to mutations in the PRNP gene), or acquired (through infection). Diagnosis is challenging because prions are not easily detected in blood or urine, and the only definitive test is brain biopsy or post-mortem examination. However, the development of the RT-QuIC (Real-Time Quaking-Induced Conversion) assay has improved diagnosis, by amplifying minute amounts of PrPSc in cerebrospinal fluid. Treatment is extremely difficult because prions are resistant to common sterilization methods and lack nucleic acids, so standard antiviral or antibiotic strategies do not work. Additionally, the blood-brain barrier limits drug delivery, and the mechanism of propagation is still not fully understood. This makes prion diseases invariably fatal, with challenges in developing therapeutics that can halt or reverse the misfolding cascade. The absence of an immune response to misfolded proteins also complicates vaccine development.